Neuralgia Treatment Global Market Report 2024

Description

“Neuralgia Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neuralgia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neuralgia treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The neuralgia treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Treatment: Drug Based; Surgeries
2) By Indication: Diabetic Neuropathy; Intercostal Neuralgia; Occipital Neuralgia; Peripheral Neuralgia; Postherpetic Neuralgia
3) By Distribution channels: Drug Stores; Hospital Pharmacies; Online Pharmacies; Retail Pharmacies
4) By End-Use: Hospitals And Clinics; Ambulatory Surgery Centers; Other End-Users
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Bayer AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Neuralgia treatment involves addressing a medical condition characterized by persistent nerve-related pain, which can result from injury, infection, or underlying medical issues. This treatment aims to effectively manage symptoms, slow the progression of neuralgia, and prevent potential complications.

Neuralgia treatment primarily falls into two categories drug-based therapies and surgical interventions. Drug-based treatment involves the use of medications to manage, alleviate, or even cure various medical conditions and diseases, including diabetic neuropathy, intercostal neuralgia, occipital neuralgia, peripheral neuralgia, and postherpetic neuralgia. These medications are accessible through various distribution channels such as drug stores, hospital pharmacies, online pharmacies, and retail pharmacies. They are utilized in diverse healthcare settings, including hospitals, clinics, ambulatory surgery centers, and other medical facilities.

The neuralgia treatment market research report is one of a series of new reports from The Business Research Company that provides neuralgia treatment market statistics, including neuralgia treatment industry global market size, regional shares, competitors with a neuralgia treatment market share, detailed neuralgia treatment market segments, market trends and opportunities and any further data you may need to thrive in the neuralgia treatment industry. This neuralgia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neuralgia treatment market size has grown strongly in recent years. It will grow from $2.15 billion in 2023 to $2.3 billion in 2024 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to rising prevalence of neuralgia, neuropathic pain awareness, rise in chronic pain conditions, presence of high disposable income, government initiatives.

The neuralgia treatment market size is expected to see strong growth in the next few years. It will grow to $2.92 billion in 2028 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to aging population, emerging therapies, increasing incidences of diabetes, high healthcare expenditure. Major trends in the forecast period include advancements in pain management, innovative products, digital health integration, development of new drug delivery systems.

The upward trajectory in the prevalence of chronic diseases, most notably diabetes, is anticipated to be a significant driver of growth for the neuralgia treatment market. Chronic ailments are characterized by their enduring nature, lasting a year or more, requiring ongoing medical attention, and often limiting daily activities. Diabetes, a persistent metabolic disorder marked by elevated blood glucose levels, is one such chronic condition. Neuralgia treatment is instrumental in addressing diabetic neuropathy, the nerve damage that can afflict individuals with diabetes. For instance, as of December 2021, data from the International Diabetes Federation, an intergovernmental organization based in the United States, revealed that diabetes had impacted 537 million adults aged 20 to 79 years in 2021. Projections indicate that this number will surge to 643 million individuals by 2030 and an estimated 783 million by 2045. Hence, the mounting prevalence of chronic diseases, prominently diabetes, is a driving force behind the expansion of the neuralgia treatment market.

The projected upswing in the volume of surgical procedures is foreseen as a key driver for the expansion of the neuralgia treatment market in the foreseeable future. Surgical procedures encompass medical interventions or therapies that entail the use of incisions or minimally invasive techniques to access and manipulate tissues or organs within the body. They are poised to contribute to the growth of neuralgia treatment by offering viable options in cases where non-surgical treatments have proven ineffective or when there exists a specific anatomical cause that can be rectified through surgery. For example, as of April 2022, data from the Aesthetic Society, an industry organization of plastic surgeons based in the United States, revealed a notable 54% increase in surgical aesthetic procedures in 2021 when compared to 2020. On average, surgeons conducted 320 procedures in 2021, marking a substantial rise from the 220 procedures performed in 2020. Thus, the upsurge in the neuralgia treatment market can be attributed to the growing number of surgical procedures.

The expense associated with neuralgia treatment can reach high levels, potentially limiting treatment accessibility and exerting a detrimental effect on market growth. The substantial cost of treatment has the capacity to significantly hinder the expansion of the neuralgia treatment market by making effective treatments less affordable and consequently reducing the overall demand in the market. Moreover, the high treatment costs may pose a significant barrier to access, particularly for patients in developing nations. For instance, in September 2022, a study featured in the Journal of Headache and Pain, a Germany-based open-access journal, assessed the long-term outcomes of a multidisciplinary trigeminal neuralgia service. The study highlighted that the expenses associated with treating trigeminal neuralgia can be notably elevated, as patients often require multiple medications and procedures throughout the course of their treatment. Hence, the elevated cost of neuralgia treatment is impeding the growth of the neuralgia treatment market.

Major players in the neuralgia treatment market are dedicated to the development of cutting-edge products and solutions to maintain their competitive edge in the industry. As an illustration, in April 2023, GlaxoSmithKline Pharmaceuticals Ltd., an India-based pharmaceutical company, introduced Shingrix, the world's first non-live recombinant subunit vaccine. This vaccine is specifically designed to prevent shingles and post-herpetic neuralgia in adults aged 50 years and above, administered intramuscularly in two doses. Shingrix leverages the antigen glycoprotein E along with the adjuvant system AS01B to generate a potent and long-lasting immune response, countering age-related immune system deterioration. Clinical trials have demonstrated its remarkable 97% effectiveness in preventing shingles in adults, while also effectively guarding against post-herpetic neuralgia, a painful complication of shingles.

In November 2022, Kriya Therapeutics Inc., a gene therapy company based in the United States, completed the acquisition of Redpin Therapeutics Inc. The specific financial details of the transaction were not disclosed. This strategic acquisition is poised to enhance Kriya Therapeutics Inc.'s gene therapy portfolio for addressing neurological disorders, encompassing conditions like epilepsy, trigeminal neuralgia, and Parkinson's disease. Redpin Therapeutics Inc., also based in the United States, is a biotechnology company with a strong track record in effectively treating a range of neurological disorders, including neuralgia.

Major players in the neuralgia treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Company Limited, Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Limited, Horizon Therapeutics, Purdue Pharma, Dr. Reddy's Laboratories, Cipla Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences Ltd., Lupin Limited, Mallinckrodt Pharmaceuticals, Glenmark Pharmaceuticals, Tonix Pharmaceuticals .

North America was the largest region in the neuralgia treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neuralgia treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the neuralgia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neuralgia treatment market consists of revenues earned by entities by providing blood tests, magnetic resonance imaging (MRI), nerve conduction velocity tests, physical therapies and alternative therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The neuralgia treatment market also includes sales of anticonvulsant medications, pain relievers, antidepressants and antiseizure medications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r12267

1. Executive Summary

2. Neuralgia Treatment Market Characteristics

3. Neuralgia Treatment Market Trends And Strategies

4. Neuralgia Treatment Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Neuralgia Treatment Market Size and Growth

5.1. Global Neuralgia Treatment Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Neuralgia Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Neuralgia Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Neuralgia Treatment Market Segmentation

6.1. Global Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Drug Based
Surgeries
6.2. Global Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Diabetic Neuropathy
Intercostal Neuralgia
Occipital Neuralgia
Peripheral Neuralgia
Postherpetic Neuralgia
6.3. Global Neuralgia Treatment Market, Segmentation By Distribution channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Drug Stores
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
6.4. Global Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals And Clinics
Ambulatory Surgery Centers
Other End-Users

7. Neuralgia Treatment Market Regional And Country Analysis

7.1. Global Neuralgia Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Neuralgia Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Neuralgia Treatment Market

8.1. Asia-Pacific Neuralgia Treatment Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Neuralgia Treatment Market

9.1. China Neuralgia Treatment Market Overview
9.2. China Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Neuralgia Treatment Market

10.1. India Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Neuralgia Treatment Market

11.1. Japan Neuralgia Treatment Market Overview
11.2. Japan Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Neuralgia Treatment Market

12.1. Australia Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Neuralgia Treatment Market

13.1. Indonesia Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Neuralgia Treatment Market

14.1. South Korea Neuralgia Treatment Market Overview
14.2. South Korea Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Neuralgia Treatment Market

15.1. Western Europe Neuralgia Treatment Market Overview
15.2. Western Europe Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Neuralgia Treatment Market

16.1. UK Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Neuralgia Treatment Market

17.1. Germany Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Neuralgia Treatment Market

18.1. France Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Neuralgia Treatment Market

19.1. Italy Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Neuralgia Treatment Market

20.1. Spain Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Neuralgia Treatment Market

21.1. Eastern Europe Neuralgia Treatment Market Overview
21.2. Eastern Europe Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Neuralgia Treatment Market

22.1. Russia Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Neuralgia Treatment Market

23.1. North America Neuralgia Treatment Market Overview
23.2. North America Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Neuralgia Treatment Market

24.1. USA Neuralgia Treatment Market Overview
24.2. USA Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Neuralgia Treatment Market

25.1. Canada Neuralgia Treatment Market Overview
25.2. Canada Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Neuralgia Treatment Market

26.1. South America Neuralgia Treatment Market Overview
26.2. South America Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Neuralgia Treatment Market

27.1. Brazil Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Neuralgia Treatment Market

28.1. Middle East Neuralgia Treatment Market Overview
28.2. Middle East Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Neuralgia Treatment Market

29.1. Africa Neuralgia Treatment Market Overview
29.2. Africa Neuralgia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Neuralgia Treatment Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Neuralgia Treatment Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Neuralgia Treatment Market Competitive Landscape And Company Profiles

30.1. Neuralgia Treatment Market Competitive Landscape
30.2. Neuralgia Treatment Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Johnson & Johnson
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. F. Hoffmann-La Roche Ltd.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Merck & Co. Inc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Bayer AG
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Neuralgia Treatment Market Other Major And Innovative Companies

31.1. Novartis AG
31.2. Bristol-Myers Squibb Company
31.3. AstraZeneca plc
31.4. Abbott Laboratories
31.5. GlaxoSmithKline plc
31.6. Eli Lilly and Company
31.7. Gilead Sciences Inc.
31.8. Teva Pharmaceutical Industries Ltd.
31.9. Mylan N.V.
31.10. Astellas Pharma Inc.
31.11. Biogen Inc.
31.12. Daiichi Sankyo Company Limited
31.13. Boehringer Ingelheim International GmbH
31.14. Sun Pharmaceutical Industries Limited
31.15. Horizon Therapeutics

32. Global Neuralgia Treatment Market Competitive Benchmarking

33. Global Neuralgia Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Neuralgia Treatment Market

35. Neuralgia Treatment Market Future Outlook and Potential Analysis

35.1 Neuralgia Treatment Market In 2028 - Countries Offering Most New Opportunities
35.2 Neuralgia Treatment Market In 2028 - Segments Offering Most New Opportunities
35.3 Neuralgia Treatment Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer